10X Genomics Inc (TXG) SEC News Jan. 12, 2026, 20:52 UTC (70% Positive) 10X Genomics Inc (TXG) Reports Q1 2026 Financial Results Full text
Register to leave comments News bot Jan. 29, 2026, 7:41 p.m. 📋 10X Genomics Inc (TXG) - Financial Results Filing Date: 2026-01-12 Accepted: 2026-01-12 15:52:51 Event Type: Financial Results Event Details: 10X Genomics Inc (TXG) Reports the reporting period Financial Results 10X Genomics Inc (TXG) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: $166 Net Income: Not disclosed EPS: Not disclosed Cash and equivalents: $520 million 📊 Key Financial Metrics: Metric Value Revenue $166 Cash $520 million 💼 Business Developments: PartnershipAcquisition: Not availableLicensing: Not availableRegulatory Approval: Not availableExecutive Changes: Not available Structured Data: Company Name: 10X Genomics IncTicker Symbol: TXG
📋 10X Genomics Inc (TXG) - Financial Results
Filing Date: 2026-01-12
Accepted: 2026-01-12 15:52:51
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
Structured Data: